These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18032414)

  • 21. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.
    Grillo MA; Colombatto S
    Amino Acids; 2008 Jun; 35(1):29-36. PubMed ID: 18008028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins--potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo.
    Hoppmann S; Haase C; Richter S; Pietzsch J
    Protein Expr Purif; 2008 Feb; 57(2):143-52. PubMed ID: 18039581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells.
    Takahashi HK; Mori S; Wake H; Liu K; Yoshino T; Ohashi K; Tanaka N; Shikata K; Makino H; Nishibori M
    J Pharmacol Exp Ther; 2009 Jul; 330(1):89-98. PubMed ID: 19380603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple and fast method to test the receptor for advanced glycosylated endproducts (RAGE) for its tumor suppressive potential using the Tet-On system.
    Bendik I; Schraml P; Ludwig CU
    J Recept Signal Transduct Res; 1999; 19(1-4):717-28. PubMed ID: 10071795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris.
    Ostendorp T; Weibel M; Leclerc E; Kleinert P; Kroneck PM; Heizmann CW; Fritz G
    Biochem Biophys Res Commun; 2006 Aug; 347(1):4-11. PubMed ID: 16806067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.
    Chen Q; Dong L; Wang L; Kang L; Xu B
    Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
    Hodgkinson CP; Laxton RC; Patel K; Ye S
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products and diabetic foot disease.
    Huijberts MS; Schaper NC; Schalkwijk CG
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S19-24. PubMed ID: 18442180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways.
    Kim JY; Park HK; Yoon JS; Kim SJ; Kim ES; Ahn KS; Kim DS; Yoon SS; Kim BK; Lee YY
    Int J Oncol; 2008 Sep; 33(3):493-501. PubMed ID: 18695878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
    Chen J; Huang L; Song M; Yu S; Gao P; Jing J
    J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
    Lim M; Park L; Shin G; Hong H; Kang I; Park Y
    Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines.
    Gefter JV; Shaufl AL; Fink MP; Delude RL
    Cell Tissue Res; 2009 Jul; 337(1):79-89. PubMed ID: 19415334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The visualization of peroxisomal proteins containing a C-terminal targeting sequence on western blot by using the biotinylated PTS1-receptor.
    Fransen M; Brees C; Van Veldhoven PP; Mannaerts GP
    Anal Biochem; 1996 Nov; 242(1):26-30. PubMed ID: 8923960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
    Wang L; Li S; Jungalwala FB
    J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
    Chen X; Zhang T; Du G
    Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.